Viewing Study NCT01334502


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2026-04-20 @ 7:31 AM
Study NCT ID: NCT01334502
Status: COMPLETED
Last Update Posted: 2017-08-10
First Post: 2011-04-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-03
Start Date Type: ACTUAL
Primary Completion Date: 2015-02
Primary Completion Date Type: ACTUAL
Completion Date: 2017-08
Completion Date Type: ACTUAL
First Submit Date: 2011-04-12
First Submit QC Date: None
Study First Post Date: 2011-04-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-08-09
Last Update Post Date: 2017-08-10
Last Update Post Date Type: ACTUAL